MENU
XENE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Xenon Pharmaceuticals (XENE) Ownership - Who owns Xenon Pharmaceuticals?
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.41B
P/E Ratio
N/A
Total Cash
626.91M
Projected Growth
N/A
Total Debt
9.02M
Revenue
N/A
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash/Share
8.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
XENE
Capitalization
2.41B
P/E Ratio
N/A
Risk (Beta)
0.36
Dividend Yield
N/A
Total Cash
627M
Total Cash/Share
8.19
Total Debt
9.02M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
755M
P/B Ratio
3.19
Cash Flow
N/A
Earnings
-3.01
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.46B
Current Ratio
17.85
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-276.74M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-26.58
Shares Held By Institutions
5.3B
Shares Outstanding - Current
76.5M
Total Liabilities
43.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
-19.745
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of drug discovery and development services
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
200-3650 Gilmore Way
Phone
+1 604 484-3300
Employees
259
Web
https://www.xenon-pharma.com